| Nov 15 |
Psychemedics Third Quarter 2024 Earnings: US$0.091 loss per share (vs US$0.36 loss in 3Q 2023)
|
| Nov 13 |
Psychemedics reports Q3 results
|
| Nov 12 |
Psychemedics: Q3 Earnings Snapshot
|
| Nov 12 |
Psychemedics Corporation Reports Third Quarter 2024 Financial Results
|
| Sep 26 |
Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing
|
| Aug 14 |
Psychemedics GAAP EPS of -$0.14, revenue of $4.7M
|
| Aug 13 |
Psychemedics: Q2 Earnings Snapshot
|
| Aug 13 |
Psychemedics Corporation Reports Second Quarter 2024 Financial Results
|
| Aug 12 |
Cannabis Stock Gainers And Losers From August 12, 2024
|
| Aug 12 |
Psychemedics approves plan to terminate registration of common stock
|
